116 related articles for article (PubMed ID: 38294283)
41. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
[TBL] [Abstract][Full Text] [Related]
42. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
43. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
45. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
[TBL] [Abstract][Full Text] [Related]
47. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
48. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
[TBL] [Abstract][Full Text] [Related]
49. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
[TBL] [Abstract][Full Text] [Related]
50. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
51. HPV-Induced Oropharyngeal Squamous Cell Carcinomas in Brazil: Prevalence, Trend, Clinical, and Epidemiologic Characterization.
Santos Carvalho R; Scapulatempo-Neto C; Curado MP; de Castro Capuzzo R; Marsico Teixeira F; Cardoso Pires R; Cirino MT; Cambrea Joaquim Martins J; Almeida Oliveira da Silva I; Oliveira MA; Watanabe M; Guimarães Ribeiro A; Caravina de Almeida G; Reis RM; Ribeiro Gama R; Lopes Carvalho A; de Carvalho AC
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1697-1707. PubMed ID: 34155066
[TBL] [Abstract][Full Text] [Related]
52. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
53. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
54. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
55. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
[TBL] [Abstract][Full Text] [Related]
56. Radiotherapy in Metastatic Oropharyngeal Cancer.
Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
[TBL] [Abstract][Full Text] [Related]
57. Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer.
White R; Abel S; Hasan S; Verma V; Greenberg L; Colonias A; Wegner RE
Laryngoscope; 2020 Apr; 130(4):E171-E176. PubMed ID: 31120601
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
[TBL] [Abstract][Full Text] [Related]
59. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
60. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]